C12N2760/16122 - page 2 - CPC Classification Index

#301

20170088848

2017-03-30

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

#302

20170072045

2017-03-16

INFLUENZA HEMAGGLUTININ PROTEINS AND METHODS OF USE THEREOF

#303

20170067029

2017-03-09

Influenza virus replication for vaccine development

#304

20170049898

2017-02-23

Influenza antigen delivery vectors and constructs

#305

20170049883

2017-02-23

Synthetic hapten carrier compositions and methods

#306

20170039314

2017-02-09

BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING

#307

20170037379

2017-02-09

Chimeric viruses presenting non-native surface proteins and uses thereof

#308

20170028053

2017-02-02

Peptide sequences and compositions

#309

20170015713

2017-01-19

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

#310

20170014506

2017-01-19

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

#311

20170000877

2017-01-05

Monovalent H5 vaccine

#312

20160375129

2016-12-29

Dimeric scaffold peptides comprising HIV-1 GP120 and GP41 epitopes

#313

20160375126

2016-12-29

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

#314

20160368950

2016-12-22

Immunogenic compositions and methods

#315

20160368949

2016-12-22

Influenza virus recombinant proteins

#316

20160362455

2016-12-15

Influenza virus vaccines and uses thereof

#317

20160362454

2016-12-15

Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses

#318

20160331828

2016-11-17

Nucleic acid vaccines

#319

20160317647

2016-11-03

Nucleic acid vaccines

#320

20160317612

2016-11-03

Engineered polypeptide agents for targeted broad spectrum influenza neutralization

#321

20160303222

2016-10-20

Compositions and methods for vaccination against influenza A virus

#322

20160279227

2016-09-29

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

#323

20160279226

2016-09-29

Computationally optimized broadly reactive antigens for H5N1 and H1N1 influenza viruses

#324

20160266117

2016-09-15

Compositions and methods for diagnosing and/or treating influenza infection

#325

20160264996

2016-09-15

Influenza virus vector for virotherapy

#326

20160228535

2016-08-11

Influenza virus mutants and uses therefor

#327

20160228534

2016-08-11

Influenza virus mutants and uses therefor

#328

20160220661

2016-08-04

Broad spectrum influenza A neutralizing vaccines and D-peptidic compounds, and methods for making and using the same

#329

20160220660

2016-08-04

Flagellin Fusion Proteins

#330

20160207963

2016-07-21

Influenza antigens and antibodies

#331

20160185826

2016-06-30

VIRUS-LIKE PARTICLE VACCINES

#332

20160175427

2016-06-23

Influenza nucleic acid molecules and vaccines made therefrom

#333

20160151480

2016-06-02

Universal influenza vaccine

#334

20160137987

2016-05-19

Recombinant influenza viruses for vaccines and gene therapy

#335

20160136260

2016-05-19

Attenuated influenza vaccines and uses thereof

#336

20160130306

2016-05-12

Human Adaptation of H7 HA

#337

20160122777

2016-05-05

Influenza virus-like particle production in plants

#338

20160095917

2016-04-07

Dps fusion proteins for use in vaccines and diagnostics

#339

20160075742

2016-03-17

Human adaptation of H3 influenza

#340

20160068823

2016-03-10

Chimeric newcastle disease viruses and uses thereof

#341

20160067328

2016-03-10

Recombinant neuraminidase and uses thereof

#342

20160053241

2016-02-25

Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use

#343

20160051662

2016-02-25

H3 influenza a virus

#344

20160051661

2016-02-25

Fluorocarbon-linked peptide formulation

#345

20160038584

2016-02-11

Vaccines for human papilloma virus and methods for using the same

#346

20160038583

2016-02-11

INFLUENZA HEMAGGLUTININ VARIANTS AND USES THEREFOR

#347

20160024479

2016-01-28

High titer recombinant influenza viruses with enhanced replication in vero cells

#348

20160022806

2016-01-28

Influenza nucleic acid molecules and vaccines made therefrom

#349

20160022805

2016-01-28

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

#350

20160008488

2016-01-14

Vectors and methods for genetic immunization

#351

20160008456

2016-01-14

Functional influenza virus-like particles (VLPS)

#352

20160000900

2016-01-07

OLIGOMERIC INFLUENZA IMMUNOGENIC COMPOSITIONS

#353

20150374813

2015-12-31

Functional influenza virus like particles (VLPs)

#354

20150368621

2015-12-24

Mutations that confer genetic stability to additional genes in influenza viruses

#355

20150353900

2015-12-10

Influenza virus reassortment

#356

20150352218

2015-12-10

Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom

#357

20150352202

2015-12-10

Broadly reactive mosaic peptide for influenza vaccine

#358

20150344909

2015-12-03

Vectors and methods for genetic immunization

#359

20150335728

2015-11-26

Methods and compositions for immunization against virus

#360

20150313989

2015-11-05

Immunogenic influenza composition

#361

20150307849

2015-10-29

Highly efficient influenza matrix (M1) proteins

#362

20150306206

2015-10-29

Functional influenza virus-like particles (VLPS)

#363

20150297712

2015-10-22

Influenza virus vaccines and uses thereof

#364

20150267203

2015-09-24

RNA silencing in animals as an antiviral defense

#365

20150265697

2015-09-24

High-yield transgenic mammalian expression system for generating virus-like particles

#366

20150246952

2015-09-03

MEANS AND METHODS FOR BREAKING NONCOVALENT BINDING INTERACTIONS BETWEEN MOLECULES

#367

20150232516

2015-08-20

Flagellin Fusion Proteins

#368

20150218579

2015-08-06

Increasing protein yield in plants

#369

20150218229

2015-08-06

Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease

#370

20150183833

2015-07-02

Deglycosylated hemagglutinin and manufacture thereof

#371

20150152143

2015-06-04

Flagellin fusion proteins

#372

20150147329

2015-05-28

Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines

#373

20150140103

2015-05-21

Isolated nucleic acid for the production of a vaccine against virus

#374

20150132330

2015-05-14

Influenza virus vaccines and uses thereof

#375

20150125423

2015-05-07

HUMAN M2E PEPTIDE IMMUNOGENS

#376

20150110836

2015-04-23

Epitope focusing by variable effective antigen surface concentration

#377

20150110832

2015-04-23

Deletion mutants of flagellin and methods of use

#378

20150099859

2015-04-09

Deletion mutants of flagellin and methods of use

#379

20150086589

2015-03-26

Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof

#380

20150056235

2015-02-26

Materials and methods for respiratory disease control in canines

#381

20150056233

2015-02-26

Influenza hemagglutinin proteins and methods of use thereof

#382

20150044247

2015-02-12

Computationally optimized broadly reactive antigens for H3N2, H2N2, and B influenza viruses

#383

20150024038

2015-01-22

Immunogenic compositions and methods

#384

20150024002

2015-01-22

Alphavirus vectors for respiratory pathogen vaccines

#385

20150017196

2015-01-15

Computationally optimized broadly reactive antigens for H5N1 and H1N1 influenza viruses

#386

20140377296

2014-12-25

H3 influenza A virus

#387

20140371295

2014-12-18

Methods and compositions to protect aquatic invertebrates from disease

#388

20140370044

2014-12-18

Modified epitopes for boosting CD4+ T-cell responses

#389

20140370041

2014-12-18

Compositions and methods for treating influenza

#390

20140357845

2014-12-04

Influenza virus vaccines and uses thereof

#391

20140356388

2014-12-04

Vaccine—screening method

#392

20140341948

2014-11-20

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

#393

20140286992

2014-09-25

Influenza virus-like particle (VLP) compositions

#394

20140271655

2014-09-18

Neutralizing anti-influenza A virus antibodies and uses thereof

#395

20140271650

2014-09-18

Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith

#396

20140255441

2014-09-11

VLPS containing ligands and methods related thereto

#397

20140255343

2014-09-11

DNA vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the H5 haemagglutinin of an influenza virus and use of the DNA vaccine

#398

20140242103

2014-08-28

Composition

#399

20140234358

2014-08-21

Newcastle disease virus vectored avian vaccines

#400

20140234356

2014-08-21

Influenza antigen delivery vectors and constructs

#401

20140227300

2014-08-14

Inhibition of innate immune response

#402

20140213640

2014-07-31

Virus-like particles for treatment of viral infections

#403

20140206603

2014-07-24

Engineered polypeptide agents for targeted broad spectrum influenza neutralization

#404

20140206556

2014-07-24

Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds

#405

20140206062

2014-07-24

Reassortant influenza viruses for vaccines

#406

20140199683

2014-07-17

Influenza B viruses having alterations in the hemagglutinin polypeptide

#407

20140194347

2014-07-10

Influenza inhibiting compositions and methods

#408

20140193448

2014-07-10

Vaccine against multitypes of avian influenza viruses and uses thereof

#409

20140193447

2014-07-10

Functional influenza virus-like particles (VLPs)

#410

20140161771

2014-06-12

Recombinant influenza viruses and constructs and uses thereof

#411

20140155476

2014-06-05

Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof

#412

20140134208

2014-05-15

Multi plasmid system for the production of influenza virus

#413

20140134199

2014-05-15

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

#414

20140127249

2014-05-08

Influenza virus mutants and uses therefor

#415

20140127248

2014-05-08

Computationally optimized broadly reactive antigens for H1N1 influenza

#416

20140127198

2014-05-08

Antigen presenting cell targeted anti-viral vaccines

#417

20140093532

2014-04-03

Immunogenic compositions in particulate form and methods for producing the same

#418

20140050755

2014-02-20

H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use

#419

20140044746

2014-02-13

Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes

#420

20140044678

2014-02-13

Chimeric Newcastle disease viruses and uses thereof

#421

20140037679

2014-02-06

Immunization of avians by administration of non-replicating vectored vaccines

#422

20140030702

2014-01-30

Modified influenza virus for monitoring and improving vaccine efficiency

#423

20140011982

2014-01-09

Antibodies against influenza virus and methods of use thereof

#424

20130337002

2013-12-19

Peptide scaffold design

#425

20130315929

2013-11-28

Vaccine antigens that direct immunity to conserved epitopes

#426

20130309205

2013-11-21

Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof

#427

20130295135

2013-11-07

Functional influenza virus like particles (VLPs)

#428

20130280296

2013-10-24

DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein

#429

20130243804

2013-09-19

Peptide sequences and compositions

#430

20130230556

2013-09-05

Herpesvirus of turkeys vectored vaccine against avian influenza in poultry

#431

20130224798

2013-08-29

Methods of making hemagglutinin proteins

#432

20130209513

2013-08-15

Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

#433

20130209499

2013-08-15

Vaccines for use in the prophylaxis and treatment of influenza virus disease

#434

20130195909

2013-08-01

Composite antigenic sequences and vaccines

#435

20130189293

2013-07-25

Influenza hemagglutinin and neuraminidase variants

#436

20130183342

2013-07-18

Computationally optimized broadly reactive antigens for influenza

#437

20130183341

2013-07-18

Influenza virus-like particles (VLPS) comprising hemagglutinin produced within a plant

#438

20130177587

2013-07-11

Functional influenza virus-like particles (VLPs)

#439

20130171186

2013-07-04

Broad spectrum influenza A neutralizing vaccines and D-peptidic compounds, and methods for making and using the same

#440

20130171181

2013-07-04

DPS fusion proteins for use in vaccines and diagnostics

#441

20130164315

2013-06-27

Vaccines - Screening Method

#442

20130164264

2013-06-27

Method of preventing or treating influenza A viral infection using cloned DI influenza A viral particles

#443

20130142826

2013-06-06

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

#444

20130139274

2013-05-30

B-cell stimulating fusion proteins of an antigen with BAFF or APRIL

#445

20130136767

2013-05-30

Compositions, methods and uses for poxvirus elements in vaccine constructs

#446

20130136763

2013-05-30

Methods of treatment with compositions that include hemagglutinin

#447

20130130314

2013-05-23

Expression of proteins in plants

#448

20130115242

2013-05-09

Modified viral strains and method for improving the production of vaccine seeds of influenza virus

#449

20130115235

2013-05-09

Swine influenza hemagglutinin variants

#450

20130101612

2013-04-25

Vaccine for enveloped viruses

#451

20130064843

2013-03-14

Identification of conserved peptide blocks in homologous polypeptides

#452

20130064839

2013-03-14

Method of rapidly producing improved vaccines for animals

#453

20130046076

2013-02-21

Crystal structure of amino terminal portion of influenza virus polymerase PA subunit and use thereof

#454

20130045232

2013-02-21

Mucosal vaccines

#455

20130045223

2013-02-21

Methods and compositions to protect aquatic invertebrates from disease

#456

20130039938

2013-02-14

Highly efficient influenza matrix (M1) proteins

#457

20130028933

2013-01-31

METHODS FOR STABILIZING INFLUENZA ANTIGEN ENVELOPED VIRUS-BASED VIRUS-LIKE PARTICLE SOLUTIONS

#458

20130023565

2013-01-24

Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use

#459

20130022637

2013-01-24

Recombinant baculovirus vaccine

#460

20130017216

2013-01-17

Modified influenza virus for monitoring and improving vaccine efficiency

#461

20120301504

2012-11-29

Influenza virus recombinant proteins

#462

20120301503

2012-11-29

Reassortant influenza B viruses

#463

20120294879

2012-11-22

CONSENSUS SEQUENCE FOR INFLUENZA A VIRUS

#464

20120288521

2012-11-15

Multi plasmid system for the production of influenza virus

#465

20120282281

2012-11-08

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

#466

20120270321

2012-10-25

Reverse genetics systems

#467

20120269849

2012-10-25

ATTENUATED INFLUENZA VIRUSES AND VACCINES

#468

20120258134

2012-10-11

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

#469

20120258077

2012-10-11

Human M2e peptide immunogens

#470

20120251568

2012-10-04

Recombinant influenza viruses and uses thereof

#471

20120244600

2012-09-27

Swine influenza hemagglutinin variants

#472

20120244521

2012-09-27

Methods for identifying a virulent strain of a virus

#473

20120244184

2012-09-27

Modified peptide vaccine derived from influenza M2

#474

20120244183

2012-09-27

Influenza viruses and uses thereof

#475

20120237536

2012-09-20

COMBINATION VACCINES AGAINST RESPIRATORY TRACT DISEASES

#476

20120231997

2012-09-13

Recombinant human CC10 protein for treatment of influenza

#477

20120231027

2012-09-13

H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use

#478

20120225067

2012-09-06

Composition and Method for Mediating an Immune Response

#479

20120219585

2012-08-30

Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines

#480

20120219584

2012-08-30

PROTECTION AGAINST PANDEMIC AND SEASONAL STRAINS OF INFLUENZA

#481

20120219579

2012-08-30

VIRUS LIKE PARTICLES COMPRISING TARGET PROTEINS FUSED TO PLANT VIRAL COAT PROTEINS

#482

20120219575

2012-08-30

Peptide sequences and compositions

#483

20120207786

2012-08-16

Functional influenza virus-like particles (VLPs)

#484

20120195926

2012-08-02

METHODS OF IMPROVING VACCINE IMMUNOGENICITY

#485

20120189658

2012-07-26

Chimeric influenza virus-like particles comprising hemagglutinin

#486

20120189657

2012-07-26

Microbial vaccine and vaccine vector

#487

20120171243

2012-07-05

Method of preparing live viral vaccines by genetic engineering of viral genome

#488

20120171218

2012-07-05

Compositions and methods for the therapy and diagnosis of influenza

#489

20120164175

2012-06-28

Influenza virus

#490

20120164155

2012-06-28

CHIMERIC MOLECULES

#491

20120156758

2012-06-21

Recombinant influenza viruses for vaccines and gene therapy

#492

20120156242

2012-06-21

An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody

#493

20120135023

2012-05-31

Influenza hemagglutinin and neuraminidase variants

#494

20120129764

2012-05-24

INFLUENZA A AND B VIRUS REPLICATION-INHIBITING PEPTIDES

#495

20120122185

2012-05-17

Chimeric viruses presenting non-native surface proteins and uses thereof

#496

20120108649

2012-05-03

Methods and compositions to protect aquatic invertebrates from disease

#497

20120107910

2012-05-03

Recombinant HIV-1 envelope proteins comprising stabilizing two-cysteine mini-domains in gp41

#498

20120107355

2012-05-03

METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS

#499

20120107343

2012-05-03

Production of recombinant proteins in ciliates and uses thereof

#500

20120076811

2012-03-29

IMMUNODOMINANT COMPOSITIONS AND METHODS OF USE THEREFOR

#501

20120073005

2012-03-22

TRANSGENIC ANIMAL CARRYING AT LEAST TWO TYPES OF FOREIGN FUNCTIONAL RNA

#502

20120070455

2012-03-22

Influenza vaccine

#503

20120058141

2012-03-08

Chimeric Newcastle disease viruses and uses thereof

#504

20120045473

2012-02-23

Biomolecule Surface Display and Uses Thereof

#505

20120040367

2012-02-16

CONSTRUCT SYSTEM AND USES THEREFOR

#506

20120034265

2012-02-09

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

#507

20120034264

2012-02-09

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

#508

20120020997

2012-01-26

Multi plasmid system for the production of influenza virus

#509

20120009215

2012-01-12

Influenza hemagglutinin and neuraminidase variants

#510

20110311994

2011-12-22

AVIAN VACCINES POSSESSING A POSITIVE MARKER GENE

#511

20110311586

2011-12-22

Materials and methods for respiratory disease control in canines

#512

20110305664

2011-12-15

Vaccines against multiple subtypes of influenza virus

#513

20110293650

2011-12-01

Influenza virus-like particles (VLPS) comprising hemagglutinin

#514

20110280899

2011-11-17

Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes

#515

20110275146

2011-11-10

FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS

#516

20110262944

2011-10-27

Construction and crystallization of expression system for RNA polymerase PB1-PB2 protein derived from influenza virus

#517

20110262481

2011-10-27

High growth reassortant influenza A virus

#518

20110250587

2011-10-13

Method for generation of RNA virus

#519

20110250237

2011-10-13

IMMUNOGENIC AMPHIPATHIC PEPTIDE COMPOSITIONS

#520

20110250232

2011-10-13

DNA transfection system for the generation of negative strand RNA virus

#521

20110206725

2011-08-25

Method for purifying protein complexes

#522

20110201547

2011-08-18

Engineered polypeptide agents for targeted broad spectrum influenza neutralization

#523

20110195091

2011-08-11

Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration

#524

20110191867

2011-08-04

PEPTIDE VACCINE FOR INFLUENZA VIRUS

#525

20110182940

2011-07-28

Method for producing purified influenza virus antigen

#526

20110182936

2011-07-28

Influenza hemagglutinin and neuraminidase variants

#527

20110171260

2011-07-14

INFLUENZA DNA VACCINATION AND METHODS OF USE THEREOF

#528

20110159034

2011-06-30

METHODS AND REAGENTS FOR VACCINATION WHICH GENERATE A CD8 T CELL IMMUNE RESPONSE

#529

20110143424

2011-06-16

RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY

#530

20110135680

2011-06-09

Deletion mutants of flagellin and methods of use

#531

20110135676

2011-06-09

Antiviral peptide against avian influenza virus H9N2

#532

20110131029

2011-06-02

Crystal structure of the influenza virus polymerase PAC-PB1complex and uses thereof

#533

20110129497

2011-06-02

Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes

#534

20110123559

2011-05-26

Swine influenza hemagglutinin variants

#535

20110117128

2011-05-19

Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof

#536

20110110978

2011-05-12

High titer recombinant influenza viruses with enhanced replication in vero cells

#537

20110104753

2011-05-05

Soluble recombinant influenza antigens

#538

20110104710

2011-05-05

RNA polymerase derived from influenza virus

#539

20110104263

2011-05-05

Claudin-4 binding peptides, compositions and methods of use

#540

20110104204

2011-05-05

Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds

#541

20110104202

2011-05-05

Modified influenza virus for monitoring and improving vaccine efficiency

#542

20110104191

2011-05-05

MALVA MOSAIC VIRUS AND VIRUS-LIKE PARTICLES AND USES THEREOF

#543

20110081373

2011-04-07

Influenza A virus with attenuating mutations in NS2 protein

#544

20110076297

2011-03-31

Peptides for inducing heterosubtypic influenza T cell responses

#545

20110070263

2011-03-24

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

#546

20110070254

2011-03-24

MUTATIONS IN THE INFLUENZA A VIRUS NS1 GENE AND USE THEREOF

#547

20110059472

2011-03-10

Reagents and methods for detecting influenza virus proteins

#548

20110059129

2011-03-10

Plant vector pBSNB-TEV, vectors derived therefrom, and methods of use

#549

20110052618

2011-03-03

Influenza hemagglutinin and neuraminidase variants

#550

20110052564

2011-03-03

ENHANCEMENT OF IMMUNOGENICITY OF ANTIGENS

#551

20110044982

2011-02-24

MULTIFUNCTIONAL LINKER PROTEIN CONTAINING AN ANTIBODY AGAINST HEMAGGLUTININ, A CONSERVED INFLUENZA ANTIGEN AND AN IMMUNOSTIMULATING CARRIER BINDING DOMAIN

#552

20110038935

2011-02-17

ANTIBODIES AGAINST INFLUENZA VIRUS AND METHODS OF USE THEREOF

#553

20110033494

2011-02-10

Anti-infective agents and uses thereof

#554

20110033490

2011-02-10

Compositions and methods for diagnosing and/or treating influenza infection

#555

20110033476

2011-02-10

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA

#556

20110027314

2011-02-03

Influenza Vaccines Containing Hemagglutinin and Matrix Proteins

#557

20110020381

2011-01-27

INFLUENZA VACCINE FORMULATION

#558

20110020374

2011-01-27

Expression system for modulating an immune response

#559

20110008838

2011-01-13

CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES

#560

20110008835

2011-01-13

System for the heterologous expression of a viral protein in a ciliate host cell

#561

20110008348

2011-01-13

Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap

#562

20110008295

2011-01-13

Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof

#563

20110002960

2011-01-06

Influenza hemagglutinin and neuraminidase variants

#564

20110002958

2011-01-06

Alphavirus Vectors for Respiratory Pathogen Vaccines

#565

20100323398

2010-12-23

Baculoviruses with enhanced virion production and a method for the production of baculoviruses

#566

20100322969

2010-12-23

Influenza B viruses having alterations in the hemaglutinin polypeptide

#567

20100316665

2010-12-16

PAPAYA MOSAIC VIRUS-BASED VACCINES AGAINST SALMONELLA TYPHI AND OTHER ENTEROBACTERIAL PATHOGENS

#568

20100310604

2010-12-09

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

#569

20100310591

2010-12-09

Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA

#570

20100303859

2010-12-02

Vectors and method for genetic immunization

#571

20100297174

2010-11-25

Influenza virus vaccines and uses thereof

#572

20100297170

2010-11-25

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

#573

20100297161

2010-11-25

Immunoprotective influenza antigen and its use in vaccination

#574

20100297114

2010-11-25

Anti-CD40 targeted fusion proteins

#575

20100291680

2010-11-18

METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION

#576

20100291082

2010-11-18

Fusion protein with HIV antigen

#577

20100291040

2010-11-18

Virus-like particles for treatment of viral infections

#578

20100286384

2010-11-11

Replikin peptides in rapid replication of glioma cells and in influenza epidemics

#579

20100285982

2010-11-11

Immunogenic peptides of influenza virus

#580

20100285592

2010-11-11

Single expression vector for generation of a virus with a segmented genome

#581

20100285063

2010-11-11

Canine influenza virus and vaccine therefore

#582

20100279273

2010-11-04

NUCLEIC ACID SEQUENCES FOR THE AMPLIFICATION AND DETECTION OF RESPIRATORY VIRUSES

#583

20100278861

2010-11-04

METHODS AND COMPOSITIONS FOR PREDICTING EMERGENCE AND EXPANSION OF DRUG RESISTANT STRAINS OF INFLUENZA VIRUS

#584

20100278860

2010-11-04

System and method for identifying complex patterns of amino acids

#585

20100256040

2010-10-07

COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION

#586

20100255029

2010-10-07

Newcastle disease virus vectored avian vaccines

#587

20100255028

2010-10-07

Flavivirus vaccine vector against influenza virus

#588

20100247572

2010-09-30

VIRUSES ENCODING MUTANT MEMBRANE PROTEIN

#589

20100247571

2010-09-30

Methods and compositions for immunization against virus

#590

20100247569

2010-09-30

Influenza A virus vaccines and inhibitors

#591

20100247550

2010-09-30

Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds

#592

20100247490

2010-09-30

Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38

#593

20100240876

2010-09-23

REPLIKINS AND METHODS OF IDENTIFYING REPLIKIN-CONTAINING SEQUENCES

#594

20100239610

2010-09-23

INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ PRODUCED WITHIN A PLANT

#595

20100239605

2010-09-23

Recombinant Rhinovirus Vectors

#596

20100233785

2010-09-16

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

#597

20100221349

2010-09-02

NUCLEIC ACID CONSTRUCTS

#598

20100215680

2010-08-26

REPLIKIN PEPTIDES AND ANTIBODIES THEREFOR

#599

20100215675

2010-08-26

Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza

#600

20100196419

2010-08-05

Virus-like particles comprising chimeric human immunodeficiency virus (HIV)/mouse mammary tumor virus (MMTV) envelopes